ArticleCancer communications (London, England)2018

Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells.

Lei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.